Fineline Cube

Follow:
14437 Articles
MicroPort Scientific's MRI-Conditional ALIZEA Hybrid Pacing System Secures CE Certification
CompanyMedical Device

MicroPort Scientific’s MRI-Conditional ALIZEA Hybrid Pacing System Secures CE Certification

AbbVie Files BLA for TrenibotE in Moderate to Severe Glabellar Lines Treatment
CompanyDrug

AbbVie Files BLA for TrenibotE in Moderate to Severe Glabellar Lines Treatment

GenFleet's KRAS G12D Inhibitor GFH375/VS-7375 Gains FDA Trial Approval
CompanyDrug

GenFleet’s KRAS G12D Inhibitor GFH375/VS-7375 Gains FDA Trial Approval

Innate Pharma and Sanofi Restructure 2016 Research Agreement on CD123 ANKET Drug
CompanyDeals

Innate Pharma and Sanofi Restructure 2016 Research Agreement on CD123 ANKET Drug

Medtronic Submits 510(k) Applications for Interoperable Diabetes Management System
CompanyMedical Device

Medtronic Submits 510(k) Applications for Interoperable Diabetes Management System

Thermo Fisher Announces $2 Billion US Investment to Strengthen Life Sciences Infrastructure
CompanyMedical Device

Thermo Fisher Announces $2 Billion US Investment to Strengthen Life Sciences Infrastructure

Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics
CompanyDeals

Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics

CN Bio and Pharmaron Partner to Validate and Expand OOC Technology Applications
CompanyDeals

CN Bio and Pharmaron Partner to Validate and Expand OOC Technology Applications

Gan & Lee Pharmaceuticals Reports 417 Million USD Revenue and 80.75% Profit Surge in 2024
Company

Gan & Lee Pharmaceuticals Reports 417 Million USD Revenue and 80.75% Profit Surge in 2024

Hepalink Secures SAHPRA Approval for Ivenoxin in South Africa
CompanyDrug

Hepalink Secures SAHPRA Approval for Ivenoxin in South Africa

Akeso's Penpulimab Gains FDA Approval for Nasopharyngeal Carcinoma Treatment
CompanyDrug

Akeso’s Penpulimab Gains FDA Approval for Nasopharyngeal Carcinoma Treatment

Sanofi Reports Q1 Sales Growth Driven by Dupixent and New Product Launches
Company

Sanofi Reports Q1 Sales Growth Driven by Dupixent and New Product Launches